Tech Center 1600 • Art Units: 1623 1631 1633 1634
This examiner grants 70% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18034620 | OVEREXPRESSION OF INSULIN-LIKE GROWTH FACTOR RECEPTOR MUTANTS TO MODULATE IGF SUPPLEMENTATION | Non-Final OA | AMGEN INC. |
| 18010857 | METHODS AND COMPOSITIONS FOR MODULATING CELLS AND CELLULAR MEMBRANES | Non-Final OA | FLAGSHIP PIONEERING INNOVATIONS VI, LLC |
| 18283744 | METHOD FOR PRODUCING PLURIPOTENT STEM CELL POPULATION | Non-Final OA | KANEKA CORPORATION |
| 18271294 | DRIED CELL SECRETOME-BASED THERAPEUTIC AGENT FOR OSTEOARTHRITIS TREATMENT | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 17904106 | METHODS FOR IMPROVED DELIVERY OF THERAPEUTIC AGENTS | Final Rejection | William Marsh Rice University |
| 17748983 | SPYCATCHER AND SPYTAG: UNIVERSAL IMMUNE RECEPTORS FOR T CELLS | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 17616522 | METHODS OF MAKING AND USING LIVER CELLS | Final Rejection | University Health Network |
| 16669191 | COMPOSITIONS AND METHODS FOR TREATING CANCER | Non-Final OA | University of Virginia Patent Foundation |
| 18341811 | HYPOTHERMIC OXYGENATED PERFUSION SOLUTION FOR REPAIRING KIDNEY INJURY AND USE THEREOF | Non-Final OA | WUHAN UNIVERSITY |
| 17997648 | SELECTION OF IMPROVED TUMOR REACTIVE T-CELLS | Final Rejection | Iovance Biotherapeutics, Inc. |
| 17628509 | CHIMERIC CYTOKINE RECEPTOR | Non-Final OA | AUTOLUS LIMITED |
| 17601684 | CELL | Non-Final OA | AUTOLUS LIMITED |
| 18246250 | STERILE ORGANISMS, METHODS OF MAKING, AND METHODS OF USE THEREOF | Non-Final OA | Brandeis University |
| 17817125 | PROCESSES FOR GENERATING SUPERIOR ANTI-TUMOR T-CELL EFFECTOR AND MEMORY CELLS | Final Rejection | MUSC Foundation for Research Development |
| 18281412 | COMPOSITION FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASES | Non-Final OA | KOLON LIFE SCIENCE, INC. |
| 18280093 | USE OF MESENCHYMAL STEM CELLS OVEREXPRESSING PACER FOR THE TREATMENT OF DISEASES WITH INFLAMMATORY ORIGIN AND/OR COMPONENT | Non-Final OA | Universidad del Desarrollo |
| 18082857 | REGENERATIVE CAR-T CELLS | Non-Final OA | CREATIVE MEDICAL TECHNOLOGIES, INC. |
| 18331956 | METHOD FOR PREPARING TUMOR-DERIVED MICROPARTICLES BY MICROWAVE | Non-Final OA | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| 17292811 | COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPY FOR CANCER | Non-Final OA | MEMORIAL SLOAN KETTERING CANCER CENTER |
| 18017107 | CLOSED MANUFACTURING PROCESSES FOR LARGE SCALE MANUFACTURING OF PLURIPOTENT STEM CELL DERIVED CELLS | Final Rejection | NCARDIA B.V. |
| 18016460 | METHODS AND COMPOSITIONS FOR TREATING LUNG CONDITIONS | Non-Final OA | BRAINSTORM CELL THERAPEUTICS LTD. |
| 17599446 | EX VIVO METHODS FOR PRODUCING A T CELL THERAPEUTIC AND RELATED COMPOSITIONS AND METHODS | Final Rejection | TURNSTONE BIOLOGICS CORP. |
| 17788908 | Inhibitor of Fertilized Egg Fragmentation | Non-Final OA | National Center for Child Health and Development |
| 17775801 | METHODS AND A KIT TO REPROGRAM SOMATIC CELLS | Non-Final OA | Atsuo Ochi |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy